Recommendations for research

The guideline committee has made the following recommendations for research.

1 Use of routinely collected real-world data to examine the effectiveness and cost effectiveness of continuous glucose monitoring

Based on routinely collected real-world data, what is the effectiveness and cost effectiveness of continuous glucose monitoring devices to improve glycaemic control in children and young people? [2022]

For a short explanation of why the committee made this recommendation for research, see the .

Full details of the evidence and the committee's discussion are in evidence review B: continuous glucose monitoring in children and young people with type 1 diabetes.

2 Effectiveness of glucose-lowering agents used to manage blood glucose levels in children and young people with type 2 diabetes

In children and young people with type 2 diabetes, what is the effectiveness of glucose-lowering agents used to manage blood glucose levels in adults with type 2 diabetes? [2023]

For a short explanation of why the committee made this recommendation and how it might affect practice, see the .

Full details of the evidence and the committee's discussion are in evidence review D: glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes.

3 Weekly treatment with glucose-lowering agents for managing blood glucose levels

In children and young people with type 2 diabetes, what is the effectiveness of weekly treatment with glucose-lowering agents for managing blood glucose levels compared to daily treatment? [2023]

For a short explanation of why the committee made this recommendation and how it might affect practice, see the .

Full details of the evidence and the committee's discussion are in evidence review D: glucose-lowering agents for managing blood glucose levels in children and young people with type 2 diabetes.

4 Continuous glucose monitor sensor adhesive to prevent sensitivities

What is the best continuous glucose monitor sensor adhesive to prevent sensitivities to the device, for example local skin reactions? [2022]

For a short explanation of why the committee made this recommendation for research, see the .

Full details of the evidence and the committee's discussion are in evidence review B: continuous glucose monitoring in children and young people with type 1 diabetes.